DOI: https://dx.doi.org/10.18565/urology.2019.6.120-124
А.А. Проскоков, С.П. Даренков, А.А. Агабекян, А.Д. Трофимчук
Кафедра урологии Центральной государственной медицинской академии Управления делами Президента РФ; ФГБУ «Клиническая больница» Управления делами Президента РФ, Москва, Россия
1. Ferlay J., Steliarova-Foucher E., Lortet-Tieulent J., Rosso S., Coebergh J.W., Comber H., Forman D., Bray F. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. European Journal of Cancer. 2013;49:1374–1403. Doi: 10.1016/j.ejca.2012.12.027. 2. Malignant neoplasia in Russia in 2014 (incidence and mortality). Pod redakciei A.D. Kaprina, V.V. Starinskogo, G.V. Petrovoi. 2016. Russian (Злокачественные новообразования в России в 2014 г. (заболеваемость и смертность) / Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М., 2016). 3. Bono A.V., Benvenuti C., Reali L. et al. Adjuvant chemotherapy in advanced bladder cancer. Italian Uro-Oncologic Cooperative Group. Prog. Clin. Biol. Res. 1989;303:533. 4. Clark P.E., Stein J.P., Groshen S.G., Cai J., Miranda G., Lieskovsky G., Skinner D.G. Radical cystectomy in the elderly: comparison of clincal outcomes between younger and older patients. Cancer. 2005;104(1):36–43. Doi: 10.1002/cncr.21126 5. World Health Organization (WHO) Consensus Conference on Bladder Cancer 1, Hautmann R.E., Abol-Enein H., Hafez K., Haro I., Mansson W., Mills R.D., Montie J.D., Sagalowsky A.I., Stein J.P., Stenzl A., Studer U.E., Volkmer B.G. Urinary diversion. Urology. 2007;69(1 Suppl):17–49. Doi: 10.1016/j.urology.2006.05.058. 6. Miller D.C., Taub D.A., Dunn R.L., Montie J.E., Wei J.T. The impact of co-morbid disease on cancer control and survival following radical cystectomy. J Urol. 2003;169(1):105–109. Doi: 10.1097/01.ju.0000039705.36504.12 7. Figueroa A.J., Stein J.P., Dickinson M., Skinner E.C., Thangathurai D., Mikhail M.S., Boyd S.D., Lieskovsky G., Skinner D.G. Radical cystectomy for elderly patients with bladder carcinoma: an updated experience with 404 patients. Cancer. 1998;83(1):141–147. 8. Extermann M., Overcash J., Lyman G.H., Parr J., Balducci L. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol. 1998;16(4):1582–1587. Doi: 10.1200/JCO.1998.16.4.1582 9. Richie J., D’Amico A. Urologic oncology, 2007. Doi: 10.1016/B978-0-7216-0003-1.X5001-1. 10. Daneshmand S. Urinary Diversion, Springer International Publishing AG 2017. 11. Daneshmand S., Ashley M.S. Continent urinary diversion in the elderly. Curr Geriatr Rep.2015;4(1):1–6. 12. Cavdar I. Sleep and quality of life in people with ileal conduit. Scand J Urol. 2016;50(6):472–476. 13. Ali A.S. et al. Health related quality of life (HRQoL) after cystectomy: comparison between orthotopic neobladder and ileal conduit diversion. Eur J Surg Oncol. 2015;41(3):295–299. 14. Ahmed M. Moeen et al Health related quality of life after urinary diversion. Which technique is better? Journal of the Egyptian National Cancer Institute. 2018;30:93–97. 15. Groeben C., Koch R. Urinary Diversion After Radical Cystectomy for Bladder Cancer: Comparing Trends in the US and Germany from 2006 to 2014. Ann Surg Oncol. 2018;25(12):3502–3509. Doi: 10.1245/s10434-018-6381-1. 16. Bachour K. et al. Trends in urinary diversion after radical cystectomy for urothelial carcinoma. World J Urol. 2018;36(3):409–416. Doi: 10.1007/s00345-017-2169-3. 17. Farber N.J., Nicholas J. Disparities in the Use of Continent Urinary Diversions after Radical Cystectomy for Bladder Cancer J. Bladder Cancer. 2018;4(1):113–120. 18. Mohamed H. Zahran Chronic urinary retention after radical cystectomy and orthotopic neobladder in women: Risk factors and relation to time. Urologic Oncology: Seminars and Original Investigations. 2017;35(2017)671.e11-e16. 19. Amini E. Long-term complications of urinary diversion. Curr Opin Urol. 2015;25(6):570–577. 20. Richard E. Hautmann. Urinary Diversion: How Experts Divert J. Urology. 2015;85(1):233–238. 21. Riedmiller H. Urinary diversion. ESU Course Urinary diversion. Geneva. 2001:1–12. 22. Thomas G. Clifford et al. Prospective Evaluation of Continence Following Radical Cystectomy and Orthotopic Urinary Diversion Using a Validated Questionnaire. The Journal of Urology. 2016. 23. Kälble T. Urinary diversion with continent umbilical stoma: Which techniques are suitable for which patients? Urologe A. 2015;54(9):1240–1247. 24. Skinner E.C. Continent cutaneous diversion. Curr Opin Urol. 2015;25(6):555–561. 25. Nayak A.L. et al. Urinary function following radical cystectomy and orthotopic neobladder urinary reconstruction. Can Urol Assoc. J. 2018;12(6):181–186. 26. Tao S. et al. Ileal versus sigmoid neobladder as bladder substitute after radical cystectomy for bladdercancer: A meta-analysis. Int J Surg. 2016;27:39–45. 27. Cerruto M.A. et al. Systematic review and meta-analysis of non RCT’s on health related quality of life after radical cystectomy using validated questionnaires: Better results with orthotopic neobladder versus ileal conduit. Eur. J. Surg. Oncol. 2016;42(3):343–360. 28. Ziouziou I. Ileal conduit vs orthotopic neobladder: Which one offers the best health-related quality of life in patients undergoing radical cystectomy? A systematic review of literature and meta-analysis. ProgUrol. 2018;28(5):241–250. 29. Yang L.S. et al. A systematic review and meta-analysis of quality of life outcomes after radical cystectomy for bladder cancer. Surg Oncol. 2016;25(3):281–297. 30. Crozier J., Hennessey D., Sengupta S., Bolton D., Lawrentschuk N.A Systematic Review of Ileal Conduit and Neobladder Outcomes in Primary Bladder Cancer. Urology. 2016;96:74–79. http://dx.doi.org/doi: 10.1016/j.urology.2016.06.034. 31. Goldberg H. et al. Orthotopic neobladder vs. ileal conduit urinary diversion: A long-term quality-of-life comparison. Uro. Oncol. 2016;34(3):121.e1-7 32. Siracusano S., Cerruto M.A., Ciciliato S. et al. Quality of life in 73 women with bladder cancer undergoing ileal orthotopic neobladder and ileal conduit: A multicentre study among long-term survivors. Eur Urol Suppl 2016;15(3);e1017. 33. Lauridsen S.V. Complications and health-related quality of life after robot-assisted versus open radical cystectomy: a systematic review and meta-analysis of four RCTs. Syst. Rev. 2017;6(1):150. Doi: 10.1186/s13643-017-0547-y. 34. Khan M.S. et al. A Single-centre Early Phase Randomised Controlled Three-arm Trial of Open, Robotic, and Laparoscopic Radical Cystectomy (CORAL). Eur Urol. 2016;69(4):613–621. 35. Tang J.Q. Robotic-assisted versus open radical cystectomy in bladder cancer: A meta-analysis of four randomized controlled trails. Int. J. Med. Robot. 2018;14(1). Doi: 10.1002/rcs.1867. 36. Xia L., Wang X., Xu T., et al. Robotic versus open radical cystectomy: an updated systematic review and meta-analysis. PLoS One. 2015;10:e0121032. 37. Wilson T.G., Guru K., Rosen R.C., Wiklund P., Annerstedt M., Bochner B.H., et al. Best practices in robot-assisted radical cystectomy and urinary reconstruction: recommendations of the Pasadena Consensus Panel. Eur Urol. 2015;67(3):363–375. 38. Nosov A.K. et al. Laparoscopic and open radical cystectomy for bladder cancer. Vopr Onkol. 2015;61(3):352–361 (In Russian). 39. Yuh B., Wilson T., Bochner B. et al. Systematic review and cumulative analysis of oncologic and functional outcomes after robotassisted radical cystectomy. Eur Urol. 2015;67(3):402–422. 40. Smith A.B., Raynor M, Amling C.L. et al. Multi-institutional analysis of robotic radical cystectomy for bladder cancer: perioperative outcomes and complications in 227 patients. J Laparoendosc Adv Surg Tech A. 2012;22:17–21. 41. Hussein A.A., Dibaj S., Hinata N., Field E., O’Leary K., Kuvshinoff B., et al. Development and validation of a quality assurance score for robot-assisted radical cystectomy: a 10-year analysis. Urology. 2016;97:124–129. 42. Tan W.S. et al. In-depth Critical Analysis of Complications Following Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion. Eur Urol Focus. 2017;3(2–3):273–279. 43. Abreu A.L. et al. Robotic radical cystectomy and intracorporeal urinary diversion: The USC technique. Indian. J Urol. 2014;30(3):300–306.
А в т о р д л я с в я з и: А. А. Агабекян – врач Центра урологии ФГБУ «Клиническая больница» Управления делами Президента РФ. Москва, Россия; e-mail: dr.agabekian@mail.ru